TGF-β in kidney fibrosis: A target for gene therapy

[1]  T. Yamamoto,et al.  Transforming Growth Factor β in Diabetic Nephropathy , 1996 .

[2]  S. Thorgeirsson,et al.  Transgenic mice with increased plasma levels of TGF-beta 1 develop progressive renal disease. , 1996, Laboratory investigation; a journal of technical methods and pathology.

[3]  Y. Kaneda,et al.  Gene therapy by skeletal muscle expression of decorin prevents fibrotic disease in rat kidney , 1996, Nature Medicine.

[4]  C. Nast,et al.  Expression of transforming growth factor-β isoforms in human glomerular diseases , 1996 .

[5]  H. Blau,et al.  Muscle-mediated gene therapy. , 1995, The New England journal of medicine.

[6]  Helen M. Blau,et al.  Molecular Medicine: Gene Therapy - A Novel Form of Drug Delivery , 1995 .

[7]  K. Sharma,et al.  Hyperglycemia and Diabetic Kidney Disease: The Case for Transforming Growth Factor–β as a Key Mediator , 1995, Diabetes.

[8]  C. Nast,et al.  Transforming growth factor-beta and matrix protein expression in acute and chronic rejection of human renal allografts. , 1995, Journal of the American Society of Nephrology.

[9]  H. Schnaper,et al.  ECM degradation by cultured human mesangial cells is mediated by a PA/plasmin/MMP-2 cascade. , 1995, Kidney international.

[10]  J. Wolff,et al.  Direct gene transfer into muscle. , 1994, Vaccine.

[11]  W. Border,et al.  Transforming Growth Factor β in Tissue Fibrosis , 1994 .

[12]  E. Ruoslahti,et al.  Interaction of the small interstitial proteoglycans biglycan, decorin and fibromodulin with transforming growth factor beta. , 1994, The Biochemical journal.

[13]  T. Yamamoto,et al.  Sustained expression of TGF-beta 1 underlies development of progressive kidney fibrosis. , 1994, Kidney international.

[14]  Y. Kaneda,et al.  Glomerulosclerosis induced by in vivo transfection of transforming growth factor-beta or platelet-derived growth factor gene into the rat kidney. , 1993, The Journal of clinical investigation.

[15]  D. Heinegård,et al.  Altered expression of small proteoglycans, collagen, and transforming growth factor-beta 1 in developing bleomycin-induced pulmonary fibrosis in rats. , 1993, The Journal of clinical investigation.

[16]  E. Ruoslahti,et al.  Coordinated expression of beta 1 integrins and transforming growth factor-beta-induced matrix proteins in glomerulonephritis. , 1993, Laboratory investigation; a journal of technical methods and pathology.

[17]  E Ruoslahti,et al.  Expression of transforming growth factor beta is elevated in human and experimental diabetic nephropathy. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[18]  M. Sporn,et al.  Transforming growth factor-beta: recent progress and new challenges , 1992, The Journal of cell biology.

[19]  W. Border,et al.  Glomerular matrix accumulation is linked to inhibition of the plasmin protease system. , 1992, Kidney international.

[20]  S. J. Elliott,et al.  The contribution of increased collagen synthesis to human glomerulosclerosis: a quantitative analysis of alpha 2IV collagen mRNA expression by competitive polymerase chain reaction , 1992, The Journal of experimental medicine.

[21]  E. Ruoslahti,et al.  Natural inhibitor of transforming growth factor-β protects against scarring in experimental kidney disease , 1992, Nature.

[22]  E. Ruoslahti,et al.  Transforming growth factor-beta in disease: the dark side of tissue repair. , 1992, The Journal of clinical investigation.

[23]  M. Sporn,et al.  Differential expression of the TGF‐β isoforms in embryogenesis suggests specific roles in developing and adult tissues , 1992, Molecular reproduction and development.

[24]  T. Nakamura,et al.  Production of extracellular matrix by glomerular epithelial cells is regulated by transforming growth factor-beta 1. , 1992, Kidney international.

[25]  D. Foreman,et al.  Control of scarring in adult wounds by neutralising antibody to transforming growth factor β , 1992, The Lancet.

[26]  H. Larjava,et al.  Differential regulation of extracellular matrix proteoglycan (PG) gene expression. Transforming growth factor-beta 1 up-regulates biglycan (PGI), and versican (large fibroblast PG) but down-regulates decorin (PGII) mRNA levels in human fibroblasts in culture. , 1991, The Journal of biological chemistry.

[27]  Erkki Ruoslahti,et al.  Proteoglycans as modulators of growth factor activities , 1991, Cell.

[28]  E. Ruoslahti,et al.  Elevated expression of transforming growth factor-beta and proteoglycan production in experimental glomerulonephritis. Possible role in expansion of the mesangial extracellular matrix. , 1990, The Journal of clinical investigation.

[29]  M. Sporn,et al.  Suppression of experimental glomerulonephritis by antiserum against transforming growth factor β1 , 1990, Nature.

[30]  M. Sporn,et al.  Peptide Growth Factors and Their Receptors I , 1990, Handbook of Experimental Pharmacology.

[31]  G. Acsadi,et al.  Direct gene transfer into mouse muscle in vivo. , 1990, Science.

[32]  T. Yamamoto,et al.  Quantitative and qualitative studies of antibody-induced mesangial cell damage in the rat. , 1987, Kidney international.

[33]  J. Rozing,et al.  Glomerulonephritis induced by monoclonal anti-Thy 1.1 antibodies. A sequential histological and ultrastructural study in the rat. , 1986, Laboratory investigation; a journal of technical methods and pathology.

[34]  W. Bennett,et al.  Role of transforming growth factor-beta 1 in experimental chronic cyclosporine nephropathy. , 1996, Kidney international.

[35]  P. Working,et al.  Pathology of recombinant human transforming growth factor-beta 1 in rats and rabbits. , 1993, International review of experimental pathology.

[36]  W. Border,et al.  In vivo interactions of TGF-β and extracellular matrix , 1992 .

[37]  J. McPherson,et al.  Differences in the biological activities of transforming growth factor-beta and platelet-derived growth factor in vivo. , 1991, Growth factors.

[38]  E. Ruoslahti,et al.  Transforming growth factor-beta regulates production of proteoglycans by mesangial cells. , 1990, Kidney international.